Recent work has continued to challenge and expand our views on the neural control of body weight. Leptin receptors have been shown to engage multiple signaling pathways in a neuron-specific pattern. The overall goals of our proposal are to decipher the crosstalk between the cAMP/PKA signaling system and the leptin receptor-initiated signals in neuronal pathways that regulate feeding and energy expenditure. Mouse genetic techniques allow us to investigate this problem in a physiological setting and also provide us with novel tools for defining regulation at the molecular level. We propose to use our newly developed ribosome-tagging approaches (RiboTag) to quantitate the translatome (mRNAs actively engaged on polyribosomes) in specific subtypes of hypothalamic neurons. Our focus will be on those groups of neurons that respond to the adipocyte-synthesized hormone, leptin, and also express the RIIb regulatory subunit of PKA. The RIIb-PKA KO mouse line is lean and resistant to diet-induced obesity and our recent results indicate that this is because of an increase in leptin sensitivity in the hypothalamus.
The specific aims of this proposal are: (1) Analyze the regulation of mRNA expression/translation in specific hypothalamic cell types by diet and hormones (2) Identify the nutritional regulators of PKA activation in the hypothalamus (3) Develop a strategy to increase the sensitivity of hypothalamic neurons to leptin by pharmacological regulation of the cAMP/PKA pathway. At the conclusion of these studies we will have completed a comprehensive analysis of mRNA transcripts in key hypothalamic neuronal populations as they respond to nutritional signals. We also expect to gain a better understanding of the mechanisms by which PKA activity can modulate leptin signaling and adiposity. The sensitivity of the hypothalamic response network to leptin is one of the ultimate determinants of how much energy an organism will store as fat. The cAMP/PKA system is well suited to pharmacological manipulation by agonists and antagonists of G-protein coupled receptors, phosphodiesterase inhibitors, and kinase activators and inhibitors. Our proposal seeks to identify potential targets within hypothalamic neurons that might be exploited to modulate leptin sensitivity as a therapeutic approach to the treatment of obesity.

Public Health Relevance

The combination of high caloric diets and lack of exercise leads to obesity and greatly increases the risk of adult onset diabetes, hypertension, and other adverse cardiovascular problems. Using a mouse model we have discovered a mutation in the cAMP/PKA signaling system that enhances the response of the brain to a hormone, leptin that is produced in fat cells and tells us to stop eating and increase metabolism. Mice with this mutation are resistant to diet-induced obesity and our proposal will study the mechanism of this protective effect with the goal of developing a therapy that will induce resistance to diet-induced obesity in humans.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Dunsmore, Sarah
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Flippo, Kyle H; Gnanasekaran, Aswini; Perkins, Guy A et al. (2018) AKAP1 Protects from Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission. J Neurosci 38:8233-8242
Li, Lei; Li, Jing; Drum, Benjamin M et al. (2017) Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve. Cardiovasc Res 113:147-159
Riggle, Kevin M; Riehle, Kimberly J; Kenerson, Heidi L et al. (2016) Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res 80:110-8
Yang, Haihua; Yang, Linghai (2016) Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy. J Mol Endocrinol 57:R93-R108
Jones, Brian W; Deem, Jennifer; Younts, Thomas J et al. (2016) Targeted deletion of AKAP7 in dentate granule cells impairs spatial discrimination. Elife 5:
Gilbert, Merle L; Yang, Linghai; Su, Thomas et al. (2015) Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype. Am J Physiol Renal Physiol 308:F627-38
Sanz, Elisenda; Quintana, Albert; Deem, Jennifer D et al. (2015) Fertility-regulating Kiss1 neurons arise from hypothalamic POMC-expressing progenitors. J Neurosci 35:5549-56
Yang, Linghai; McKnight, G Stanley (2015) Hypothalamic PKA regulates leptin sensitivity and adiposity. Nat Commun 6:8237
Yang, Linghai; Gilbert, Merle L; Zheng, Ruimao et al. (2014) Selective expression of a dominant-negative type I? PKA regulatory subunit in striatal medium spiny neurons impairs gene expression and leads to reduced feeding and locomotor activity. J Neurosci 34:4896-904
Vulto-van Silfhout, Anneke T; Rajamanickam, Shivakumar; Jensik, Philip J et al. (2014) Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems. Am J Hum Genet 94:649-61

Showing the most recent 10 out of 84 publications